Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone

Journal of Biological Chemistry

Volumn 286, Issue 30, 2011, Pages 26978-26986

  Anderson, David G ^a   Mariappan, S V Santhana ^b   Buettner, Garry R ^c   Doorn, Jonathan A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS MEDIA; AUTOOXIDATION; CHEMICAL OXIDATION; CYCLOOXYGENASE 2; ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY; HYDRATED FORMS; MONOAMINE OXIDASE; NEURODEGENERATION; OXIDATION PRODUCTS; PARKINSON DISEASE; PROTEIN CROSSLINKING; REACTIVE RADICALS; SEMIQUINONE RADICALS; SUPEROXIDES;

BRAIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; HYDRATION; METABOLISM; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE; OXYGEN; PARAMAGNETIC RESONANCE; PARAMAGNETISM; PHYSIOLOGY; SPECTROSCOPY; TOXICITY;

OXIDATION;

3,4 DIHYDROXYPHENYLACETALDEHYDE; ACETALDEHYDE; AMINE OXIDASE (FLAVIN CONTAINING); CYCLOOXYGENASE 2; DOPAMINE; ORTHO QUINONE; QUINONE DERIVATIVE; RADICAL; SEMIQUINONE; SUPEROXIDE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTRON SPIN RESONANCE; HYDRATION; METABOLITE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; TOXICITY;

3,4-DIHYDROXYPHENYLACETIC ACID; BENZOQUINONES; CYCLOOXYGENASE 2; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; PARKINSON DISEASE;

EID: 79960686500     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.249532     Document Type: Article

References (57)

1. Davie, C. A. (2008) Br. Med. Bull. 86, 109-127
2. Chinta, S. J., and Andersen, J. K. (2008) Biochim. Biophys. Acta 1780, 1362-1367
3. Fornstedt, B., Brun, A., Rosengren, E., and Carlsson, A. (1989) J. Neural Transm. Park. Dis. Dement. Sect. 1, 279-295
4. Collins, M. A., and Neafsey, E. J. (2002) Neurotoxicol. Teratol. 24, 571-577
5. Terland, O., Almas, B., Flatmark, T., Andersson, K. K., and Sorlie, M. (2006) Free Radic. Biol. Med. 41, 1266-1271
6. Goncalves, L. L., Ramkissoon, A., and Wells, P. G. (2009) Chem. Res. Toxicol. 22, 842-852
7. Graham, D. G. (1978) Mol. Pharmacol. 14, 633-643
8. Graham, D. G., Tiffany, S. M., Bell, W. R., Jr., and Gutknecht, W. F. (1978) Mol. Pharmacol. 14, 644-653
9. Stokes, A. H., Hastings, T. G., and Vrana, K. E. (1999) J. Neurosci. Res. 55, 659-665
10. Halliwell, B. (1992) J. Neurochem. 59, 1609-1623
11. Hastings, T. G., Lewis, D. A., and Zigmond, M. J. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 1956-1961
12. Akagawa, M., Ishii, Y., Ishii, T., Shibata, T., Yotsu-Yamashita, M., Suyama, K., and Uchida, K. (2006) Biochemistry 45, 15120-15128
13. Burke, W. J., Li, S. W., Chung, H. D., Ruggiero, D. A., Kristal, B. S., Johnson, E. M., Lampe, P., Kumar, V. B., Franko, M., Williams, E. A., and Zahm, D. S. (2004) Neurotoxicology 25, 101-115
14. Burke, W. (2003) Curr. Drug Targets CNS Neurol. Disord. 2, 143-148
15. Burke, W. J., Li, S. W., Williams, E. A., Nonneman, R., and Zahm, D. S. (2003) Brain Res. 989, 205-213
16. Marchitti, S. A., Deitrich, R. A., and Vasiliou, V. (2007) Pharmacol. Rev. 59, 125-150
17. Rees, J. N., Florang, V. R., Anderson, D. G., and Doorn, J. A. (2007) Chem. Res. Toxicol. 20, 1536-1542
18. Rees, J. N., Florang, V. R., Eckert, L. L., and Doorn, J. A. (2009) Chem. Res. Toxicol. 22, 1256-1263
19. Kristal, B. S., Conway, A. D., Brown, A. M., Jain, J. C., Ulluci, P. A., Li, S. W., and Burke, W. J. (2001) Free Radic. Biol. Med. 30, 924-931
20. Li, S. W., Lin, T. S., Minteer, S., and Burke, W. J. (2001) Mol. Brain Res. 93, 1-7
21. Hashimoto, T., and Yabe-Nishimura, C. (2002) Brain Res. 931, 96-99
22. Mattammal, M. B., Haring, J. H., Chung, H. D., Raghu, G., and Strong, R. (1995) Neurodegeneration 4, 271-281
23. Fellman, J. H. (1958) Nature 182, 311-312
24. Jinsmaa, Y., Florang, V. R., Rees, J. N., Anderson, D. G., Strack, S., and Doorn, J. A. (2009) Chem. Res. Toxicol. 22, 835-841
25. Li, S. W., Spaziano, V. T., and Burke, W. J. (1998) Bioorg. Chem. 26, 45-50
26. Tsukamoto, S., Kato, H., Hirota, H., and Fusetani, N. (1994) Tetrahedron 50, 13583-13592
27. Buettner, G. R. (1986) Free Radic. Res. Commun. 1, 349-353
28. Kalyanaraman, B., and Sealy, R. C. (1982) Biochem. Biophys. Res. Commun. 106, 1119-1125
29. Kalyanaraman, B., Felix, C. C., and Sealy, R. C. (1985) Environ. Health Perspect. 64, 185-198
30. Song, Y., Wagner, B. A., Lehmler, H. J., and Buettner, G. R. (2008) Chem. Res. Toxicol. 21, 1359-1367
31. Duling, D. R. (1994) J. Magn. Reson. B 104, 105-110
32. Adams, M., Blois, M. S., and Sands, R. H. (1958) J. Chem. Phys. 28, 774-776
33. Eyer, P. (1991) Chem. Biol. Interact. 80, 159-176
34. Wangpradit, O., Mariappan, S. V., Teesch, L. M., Duffel, M. W., Norstrom, K., Robertson, L. W., and Luthe, G. (2009) Chem. Res. Toxicol. 22, 64-71
35. Land, E. J., Simic, M., and Swallow, A. J. (1971) Biochim. Biophys. Acta 226, 239-240
36. Kirima, K., Tsuchiya, K., Yoshizumi, M., Kameda, T., Houchi, H., Azuma, M., and Tamaki, T. (2001) Chem. Pharm. Bull. (Tokyo) 49, 576-580
37. Chang, L. Y., Slot, J. W., Geuze, H. J., and Crapo, J. D. (1988) J. Cell Biol. 107, 2169-2179
38. Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., and Stephenson, A. H. (1995) J. Neurochem. 64, 1645-1654
39. Chae, S. W., Kang, B. Y., Hwang, O., and Choi, H. J. (2008) Neurosci. Lett. 436, 205-209
40. Eisenhofer, G., Kopin, I. J., and Goldstein, D. S. (2004) Pharmacol. Rev. 56, 331-349
41. Lamensdorf, I., He, L., Nechushtan, A., Harvey-White, J., Eisenhofer, G., Milan, R., Rojas, E., and Kopin, I. J. (2000) Eur. J. Pharmacol. 388, 147-154
42. Carey, F. A., and Sundberg, R. J. (2000) Advanced Organic Chemistry, Part A: Structure and Mechanisms, 4th Ed., pp. 449-451, Kluwer Academic/Plenum Publishers, New York
43. LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., and Selkoe, D. J. (2005) Nat. Med. 11, 1214-1221
44. Nakajima, H., Amano, W., Fukuhara, A., Kubo, T., Misaki, S., Azuma, Y. T., Inui, T., and Takeuchi, T. (2009) Biochem. Biophys. Res. Commun. 390, 1066-1071
45. Nakajima, H., Amano, W., Kubo, T., Fukuhara, A., Ihara, H., Azuma, Y. T., Tajima, H., Inui, T., Sawa, A., and Takeuchi, T. (2009) J. Biol. Chem. 284, 34331-34341
46. Nakajima, H., Amano, W., Fujita, A., Fukuhara, A., Azuma, Y. T., Hata, F., Inui, T., and Takeuchi, T. (2007) J. Biol. Chem. 282, 26562-26574
47. Song, Y., and Buettner, G. R. (2010) Free Radic. Biol. Med. 49, 919-962
48. Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., and Marsden, C. D. (1989) J. Neurochem. 53, 692-697
49. Baillet, A., Chanteperdrix, V., Trocme, C., Casez, P., Garrel, C., and Besson, G. (2010) Neurochem. Res. 35, 1530-1537
50. Wangpradit, O., Moman, E., Nolan, K. B., Buettner, G. R., Robertson, L. W., and Luthe, G. (2010) Chemosphere 81, 1501-1508
51. Bartels, A. L., and Leenders, K. L. (2010) Curr. Neuropharmacol. 8, 62-68
52. Minghetti, L. (2004) J. Neuropathol. Exp. Neurol. 63, 901-910
53. Teismann, P., Vila, M., Choi, D. K., Tieu, K., Wu, D. C., Jackson-Lewis, V., and Przedborski, S. (2003) Ann. N.Y. Acad. Sci. 991, 272-277
54. Asanuma, M., Miyazaki, I., and Ogawa, N. (2004) Curr. Pharm. Des. 10, 695-700
55. Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H. C., Cass, W. A., Sullivan, P. G., and Bing, G. (2007) J. Neurochem. 100, 1375-1386
56. Vijitruth, R., Liu, M., Choi, D. Y., Nguyen, X. V., Hunter, R. L., and Bing, G. (2006) J. Neuroinflammation 3, 6
57. Feng, Z., Li, D., Fung, P. C., Pei, Z., Ramsden, D. B., and Ho, S. L. (2003) Neuroreport 14, 1927-1929